What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast.
Savini
Vincenzo
V
Clinical Microbiology and Virology Unit, Department of Transfusion Medicine, Spirito Santo Hospital, Pescara, Italy. vincsavi@yahoo.it
Catavitello
Chiara
C
Onofrillo
Daniela
D
Masciarelli
Gioviana
G
Astolfi
Daniela
D
Balbinot
Andrea
A
Febbo
Fabio
F
D'Amario
Claudio
C
D'Antonio
Domenico
D
D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use; D002175:Candida / Q000145:classification / Q000302:isolation & purification*; D002177:Candidiasis / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D021821:Communicable Diseases, Emerging / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology*; D025141:Drug Resistance, Fungal; D006801:Humans; D016867:Immunocompromised Host; D008826:Microbial Sensitivity Tests; D017211:Treatment Failure
D000935:Antifungal Agents